FIDIA Farmaceutici to Attend the 26th EWMA Conference in Bremen

An opportunity to showcase FIDIA's unique products in the wound healing area

FIDIA Farmaceutici S.p.A., the Italian pharmaceutical company leader in hyaluronic acid (HY) - based products, will be present at the 26th Conference of the European Wound Management Association (EWMA), May 11-13, 2016 at the Messe Bremen (Germany).

The EWMA conference offers high level scientific presentations, networking activities and it is an excellent opportunity to exchange knowledge and experiences with international colleagues, from over 80 countries worldwide.

The theme of this year's meeting is “Wound care from a human rights perspective". Fidia has organized a symposium focused on “The regenerative approach as new option on wound care”, that will take place on 11th May at 3.30 PM in the Lloyd Room.

The Company will be also present in the Exhibition area with booth n° 5 I 12 – Hall 5.0. Level 0.


Find out more about Fidia’s product portfolio:

Go to the website


Fidia Farmaceutici has a specific module dedicated to Pharmaco-Vigilance in order to promptly reporting of suspected adverse reactions. If you suspect that you have had an adverse reaction while taking one of our products or you have found defects

Key Business Areas

Fidia operates in numerous therapeutic areas, providing specific, innovative treatments for commonly occurring pathologies with major socio-economic impact, namely:

- joint care
- ophthalmology
- active wound care
- neuroscience
- aesthetic medicine